2018
DOI: 10.1248/bpb.b17-00818
|View full text |Cite
|
Sign up to set email alerts
|

<i>Juniperus chinensis</i> Fruits Attenuate Oxazolone- and 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis Symptoms in Mice

Abstract: Juniperus chinensis, commonly Chinese juniper, has been used for treating inflammatory diseases. This study aimed to investigate anti-atopic dermatitis (AD) effects of standardized J. chinensis fruits extract on murine oxazolone- and 2,4-dinitrochlorobenzene (DNCB)-induced models of AD. Ear swelling, epidermis thickening, and eosinophils infiltration in the oxazolone-mediated dermatitis of BALB/c mice were significantly reduced upon topical application of J. chinensis fruits 95% EtOH extract (JCE). Besides, tr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 28 publications
0
1
0
Order By: Relevance
“…Notably, many flavonoids are well-known NF-κB inhibitors and also possess inhibitory activity on different PDE isoforms, including PDE4 [45,46]. Among them, the flavone apigenin was shown, on the one hand, to non-selectively inhibit PDE4 [47] and, on the other, to reduce the levels of proallergic cytokines in models of asthma and atopic dermatitis [48,49]; however, a causal link between the two effects could not be established. For these reasons, we decided to further correlate the effect of RNLE with that of crisaborole (0.5 µ M), a topical PDE4 inhibitor approved in 2016 by FDA for the treatment of AD.…”
Section: Rnle Inhibits Tnf-α/il-4-induced Tslp Release In Differentiated Hacat Cells With a Camp-independent Mechanismmentioning
confidence: 99%
“…Notably, many flavonoids are well-known NF-κB inhibitors and also possess inhibitory activity on different PDE isoforms, including PDE4 [45,46]. Among them, the flavone apigenin was shown, on the one hand, to non-selectively inhibit PDE4 [47] and, on the other, to reduce the levels of proallergic cytokines in models of asthma and atopic dermatitis [48,49]; however, a causal link between the two effects could not be established. For these reasons, we decided to further correlate the effect of RNLE with that of crisaborole (0.5 µ M), a topical PDE4 inhibitor approved in 2016 by FDA for the treatment of AD.…”
Section: Rnle Inhibits Tnf-α/il-4-induced Tslp Release In Differentiated Hacat Cells With a Camp-independent Mechanismmentioning
confidence: 99%